Benzinga | Nov 5, 2021 09:23AM EDT

Aerie Pharmaceuticals Q3 EPS $(0.86) Misses $(0.62) Estimate, Sales $29.30M Beat $28.89M Estimate

Aerie Pharmaceuticals (NASDAQ:AERI) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.62) by 38.71 percent. This is unchanged from the same period last year. The company reported quarterly sales of $29.30 million which beat the analyst consensus estimate of $28.89 million by 1.42 percent. This is a 45.91 percent increase over sales of $20.08 million the same period last year.